JP2024153733A5 - - Google Patents

Download PDF

Info

Publication number
JP2024153733A5
JP2024153733A5 JP2024118341A JP2024118341A JP2024153733A5 JP 2024153733 A5 JP2024153733 A5 JP 2024153733A5 JP 2024118341 A JP2024118341 A JP 2024118341A JP 2024118341 A JP2024118341 A JP 2024118341A JP 2024153733 A5 JP2024153733 A5 JP 2024153733A5
Authority
JP
Japan
Prior art keywords
cdr
seq
antibody
nucleic acid
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024118341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024153733A (ja
Filing date
Publication date
Priority claimed from PCT/CA2020/051103 external-priority patent/WO2021026652A1/en
Application filed filed Critical
Publication of JP2024153733A publication Critical patent/JP2024153733A/ja
Publication of JP2024153733A5 publication Critical patent/JP2024153733A5/ja
Pending legal-status Critical Current

Links

JP2024118341A 2019-08-12 2024-07-24 Frizzled受容体抗体およびその使用 Pending JP2024153733A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962885781P 2019-08-12 2019-08-12
US62/885,781 2019-08-12
US201962886292P 2019-08-13 2019-08-13
US62/886,292 2019-08-13
PCT/CA2020/051103 WO2021026652A1 (en) 2019-08-12 2020-08-12 Frizzled receptor antibodies and uses thereof
JP2022509038A JP7631309B2 (ja) 2019-08-12 2020-08-12 Frizzled受容体抗体およびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022509038A Division JP7631309B2 (ja) 2019-08-12 2020-08-12 Frizzled受容体抗体およびその使用

Publications (2)

Publication Number Publication Date
JP2024153733A JP2024153733A (ja) 2024-10-29
JP2024153733A5 true JP2024153733A5 (enExample) 2025-06-06

Family

ID=74570316

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022509038A Active JP7631309B2 (ja) 2019-08-12 2020-08-12 Frizzled受容体抗体およびその使用
JP2024118341A Pending JP2024153733A (ja) 2019-08-12 2024-07-24 Frizzled受容体抗体およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022509038A Active JP7631309B2 (ja) 2019-08-12 2020-08-12 Frizzled受容体抗体およびその使用

Country Status (7)

Country Link
US (1) US20220356256A1 (enExample)
EP (1) EP4013793A4 (enExample)
JP (2) JP7631309B2 (enExample)
CN (2) CN114616246B (enExample)
AU (1) AU2020328475A1 (enExample)
CA (1) CA3147689A1 (enExample)
WO (1) WO2021026652A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114450424B (zh) 2019-09-30 2023-10-31 杰富意钢铁株式会社 金属带急冷装置、金属带急冷方法以及金属带产品的制造方法
WO2023250402A2 (en) * 2022-06-22 2023-12-28 Antlera Therapeutics Inc. Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130295106A1 (en) * 2008-09-26 2013-11-07 Oncomed Pharmaceuticals, Inc. Frizzled-Binding Agents And Uses Thereof
NZ592338A (en) * 2008-09-26 2012-11-30 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
EP3033356B1 (en) * 2013-08-14 2020-01-15 Sachdev Sidhu Antibodies against frizzled proteins and methods of use thereof
WO2017127933A1 (en) * 2016-01-29 2017-08-03 The Governing Council Of The University Of Toronto Frizzled protein-binding agents and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2024153733A5 (enExample)
JP2020063262A5 (enExample)
JP2020510422A5 (enExample)
JP2022516505A (ja) 癌および他の疾患の治療のための、クローディン18.2に特異的な結合分子、その組成物および方法
JP2020114210A5 (enExample)
RU2018129962A (ru) Композиции антител к ror1 и соответствующие способы
JP2021503455A5 (enExample)
JP2018524349A5 (enExample)
JP2019513018A5 (enExample)
ME02637B (me) Antitela za receptor 3 faktora rasta epiderma (her3)
JPWO2020068752A5 (enExample)
RU2009115363A (ru) Антагонисты рецепторов для лечения метастатического рака
RU2019143101A (ru) Новое анти-с-мет антитело и его применение
JP2024001073A5 (enExample)
JPWO2022159620A5 (enExample)
JPWO2020114480A5 (enExample)
CN114829405B (zh) 抗bcma/抗4-1bb双特异性抗体及其用途
JPWO2019210848A5 (enExample)
JPWO2021129672A5 (enExample)
AU2019306113B2 (en) Anti-human PD-L1 antibodies and their uses
JPWO2020076799A5 (enExample)
JPWO2019152895A5 (enExample)
JPWO2021026666A5 (enExample)
JPWO2020028428A5 (enExample)
RU2024137724A (ru) Антитела, которые связываются с белками lrp5, и способы применения